Stier, who directs the National Center’s Risk Analysis Division, also will moderate a panel on strategies and goals for advancing harm reduction after the FDA announces its new regulations on e-cigarettes, which is expected sometime next month.
“Reducing the harm associated with tobacco use is a legitimate aim for health agencies, policymakers, regulators and the tobacco industry alike,” said Stier. “What is needed to determine how best to achieve this is good quality science, designed, conducted and analyzed using well-established scientific standards, as well as the discipline to distinguish between association and causation. Poorly-executed studies run the risk of misinforming both the public and governments about how best to reduce the harm from tobacco use. They can undermine regulatory aims and do more harm than good.”
“Poor science,” Stier added, “undermines the public health community’s most valuable asset: its reputation for adherence to strong scientific principles.”
The headline speaker for the conference is Mitch Zeller, J.D., director of the FDA’s Center for Tobacco Products.
A complete list of scheduled panels and presentations over the two-day conference, as well as registration information, can be found by visiting http://sfata.org/may2015/.